ClassID:

95260

C07D405/12 - page 28 - CPC Classification

Classification description:

Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#8101
20050267185
2005-12-01

1,2,4-triazole derivatives, compositions, process of making and methods of use

#8102
20050267182
2005-12-01

Urea derivatives as FLT-3 modulators

#8103
20050267171
2005-12-01

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#8104
20050267163
2005-12-01

Vanilloid receptor ligands and their use in treatments

#8105
20050267147
2005-12-01

Benzimidazole and imidazopyridine derivatives and use thereof as a medicament

#8106
20050267122
2005-12-01

Ansamycins having improved pharmacological and biological properties

#8107
20050267119
2005-12-01

Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions

#8108
20050267110
2005-12-01

Propane-1, 3-dione derivative

#8109
20050267098
2005-12-01

Modulators of cellular adhesion

#8110
20050267095
2005-12-01

3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands

#8111
20050267043
2005-12-01

Inhibitors of hepatitis C virus NS3 protease

#8112
20050261501
2005-11-24

Pyrrolidine and thiazolidine compounds

#8113
20050261496
2005-11-24

Tyrosine kinase inhibitors

#8114
20050261343
2005-11-24

Anthranilamides and their use as pharmaceutical agents

#8115
20050261327
2005-11-24

2-(Bicyclo)alkylamino-derivatives as mediatores of chronic pain and inflammation

#8116
20050261319
2005-11-24

Novel 2-amino-4-quinazolinones and 2-amino-4-oxoquinazolones as LXR nuclear receptor binding compounds with partial agonistic properties

#8117
20050261315
2005-11-24

Substituted 3-carboxamido isoxazoles as kinase modulators

#8118
20050261313
2005-11-24

Process for preparing 3,3-dimethylindolines

#8119
20050261294
2005-11-24

Substituted heteroaryl derivatives, compositions, and methods of use

#8120
20050261293
2005-11-24

Compounds which inhibit leukocyte adhesion mediated by VLA-4

#8121
20050261268
2005-11-24

Aminotriazole compounds useful as inhibitors of protein kinases

#8122
20050256185
2005-11-17

Spiro and dispiro 1,2,4-trioxolane antimalarials

#8123
20050256180
2005-11-17

Substituted pyrazolyl compounds for the treatment of inflammation

#8124
20050256170
2005-11-17

EP2 receptor agonists

#8125
20050256164
2005-11-17

NK1 and NK3 antagonists

#8126
20050256160
2005-11-17

β-alanine derivatives and the use thereof

#8127
20050256122
2005-11-17

Substituted pyridazinones

#8128
20050256105
2005-11-17

Protease inhibitors

#8129
20050256104
2005-11-17

Protease inhibitors

#8130
20050256100
2005-11-17

Protease inhibitors

#8131
20050256066
2005-11-17

Fredericamycin derivatives

#8132
20050256000
2005-11-17

Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use

#8133
20050250846
2005-11-10

Non-peptide GnRH agents, pharmaceutical compositions and methods for their use

#8134
20050250818
2005-11-10

Ortho substituted aryl or heteroaryl amide compounds

#8135
20050250810
2005-11-10

Fab I inhibitors

#8136
20050250797
2005-11-10

Quinzoline derivatives for use in the treatment of cancer

#8137
20050250792
2005-11-10

Substituted piperidine compounds useful as modulators of chemokine receptor activity

#8138
20050250789
2005-11-10

Hydroxamic acid derivatives as metalloprotease inhibitors

#8139
20050250774
2005-11-10

Pyridine compounds

#8140
20050250707
2005-11-10

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

#8141
20050245746
2005-11-03

Anomeric derivatives of monosaccharides

#8142
20050245596
2005-11-03

Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss

#8143
20050245586
2005-11-03

2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12

#8144
20050245572
2005-11-03

Naphthyl ether compounds and their use

#8145
20050245555
2005-11-03

Tri-substituted ureas as cytokine inhibitors

#8146
20050245551
2005-11-03

Amide derivatives

#8147
20050245547
2005-11-03

Compounds and methods of use

#8148
20050245525
2005-11-03

Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1

#8149
20050245503
2005-11-03

Therapeutic heterocycles

#8150
20050245501
2005-11-03

Succinoylamino lactams as inhibitors of A-β protein production

#8151
20050245399
2005-11-03

Pyrazole derivatives as herbicidal compositions containing them

#8152
20050240035
2005-10-27

Non-nucleoside reverse transcriptase inhibitors

#8153
20050239841
2005-10-27

New compounds

#8154
20050239836
2005-10-27

Substituted hydroxyethylamine aspartyl protease inhibitors

#8155
20050239829
2005-10-27

Piperidine compounds

#8156
20050239826
2005-10-27

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

#8157
20050239811
2005-10-27

Tri-substituted ureas as cytokine inhibitors

#8158
20050239801
2005-10-27

Novel compounds

#8159
20050239794
2005-10-27

Substituted tricyclic compounds as protein kinase inhibitors

#8160
20050239793
2005-10-27

Substituted tricyclic compound as protein kinase inhibitors

#8161
20050239790
2005-10-27

Substituted hydroxyethylamine aspartyl protease inhibitors

#8162
20050239777
2005-10-27

Quinazoline derivatives and pharmaceutical compositions containing them

#8163
20050234117
2005-10-20

Triazoles as farnesyl transferase inhibitors

#8164
20050234082
2005-10-20

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

#8165
20050234057
2005-10-20

1-phenylpiperidin-3-one derivatives and processes for the preparation thereof

#8166
20050234049
2005-10-20

Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds

#8167
20050234045
2005-10-20

N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones

#8168
20050234044
2005-10-20

Cyclic amine derivatives and methods of use

#8169
20050234042
2005-10-20

Organic compounds

#8170
20050234041
2005-10-20

Substituted 1-benzazepines and derivatives thereof

#8171
20050234031
2005-10-20

Amino-substituted tricyclic derivatives and methods of use

#8172
20050233979
2005-10-20

Caspase inhibitors and uses thereof

#8173
20050228029
2005-10-13

Platelet ADP receptor inhibitors

#8174
20050228018
2005-10-13

Chemical compounds

#8175
20050228011
2005-10-13

Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists

#8176
20050227992
2005-10-13

Substituted tricyclic compounds as protein kinase inhibitors

#8177
20050227986
2005-10-13

Vanilloid receptor ligands and their use in treatments

#8178
20050222408
2005-10-06

Heterocyclic amides with anti-tuberculosis activity

#8179
20050222247
2005-10-06

Chroman derivatives

#8180
20050222239
2005-10-06

Pyrazole-amine compounds for the treatment of neurodegenerative disorders

#8181
20050222237
2005-10-06

Inhibitors of GSK-3 and uses thereof

#8182
20050222230
2005-10-06

3,4-diarylpyrazoles and their use in the therapy of cancer

#8183
20050222207
2005-10-06

Phosphodiesterase 4 inhibitors, including N-substituted diarylamine analogs

#8184
20050222203
2005-10-06

Nitrogen heterocycle biaryls for osteoporosis and other diseases

#8185
20050222200
2005-10-06

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

#8186
20050222152
2005-10-06

Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives

#8187
20050222124
2005-10-06

Benzenesulfonamide derivatives as antipsychotic agents

#8188
20050222118
2005-10-06

Azetidine derivatives as CCR-3 receptor antagonists

#8189
20050221989
2005-10-06

O-cyclopropyl-carboxanilides and their use as fungicides

#8190
20050215794
2005-09-29

Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds

#8191
20050215788
2005-09-29

Method for the purification of Piribedil

#8192
20050215784
2005-09-29

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

#8193
20050215616
2005-09-29

2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

#8194
20050215614
2005-09-29

Substituted indoles and their use as hcv inhibitors

#8195
20050215610
2005-09-29

Imidazole compounds for the treatment of neurodegenerative disorders

#8196
20050215594
2005-09-29

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists

#8197
20050215573
2005-09-29

Inhibitors of glutaminyl cyclase

#8198
20050215561
2005-09-29

Pharmaceutical dosage forms and compositions

#8199
20050215559
2005-09-29

Substituted arylpyrazines

#8200
20050215526
2005-09-29

Melanin concentrating hormone receptor antagonist

#8201
20050209437
2005-09-22

Polymer compounds containing oxetane and maleimide functionality

#8202
20050209324
2005-09-22

Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents

#8203
20050209285
2005-09-22

Compounds and compositions as protein kinase inhibitors

#8204
20050209282
2005-09-22

Benzimidazoles useful as modulators of ion channels

#8205
20050209278
2005-09-22

Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors

#8206
20050209274
2005-09-22

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

#8207
20050209273
2005-09-22

Metabotropic glutamate receptor antagonists

#8208
20050209260
2005-09-22

Diaminopyrimidines as P2Xand P2Xantagonists

#8209
20050209245
2005-09-22

Process for preparing N-aryl-piperazine derivatives

#8210
20050209231
2005-09-22

Compositions and methods for inducing cardiomyogenesis

#8211
20050209230
2005-09-22

5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

#8212
20050209224
2005-09-22

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#8213
20050209213
2005-09-22

Quinoline compound

#8214
20050209162
2005-09-22

Methods for monitoring IL-18

#8215
20050203294
2005-09-15

Process for the preparation of benazepril hydrochloride

#8216
20050203173
2005-09-15

PI-3 kinase inhibitor prodrugs

#8217
20050203159
2005-09-15

Ion channel modulators

#8218
20050203145
2005-09-15

6-alkylamino-2,2′-disubstituted-7,8-disubstituted-2H-1-benzopyran derivatives as 5-lipoxygenase inhibitor

#8219
20050203140
2005-09-15

Process for the preparation of paroxetine substantially free of alkoxy impurities

#8220
20050203138
2005-09-15

Biphenyl compounds useful as muscarinic receptor antagonists

#8221
20050203112
2005-09-15

Bicyclic amides

#8222
20050203093
2005-09-15

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#8223
20050203083
2005-09-15

Biphenyl compounds useful as muscarinic receptor antagonists

#8224
20050197371
2005-09-08

Urea derivatives as PDGFR modulators

#8225
20050197364
2005-09-08

Amide compounds as ion channel ligands and uses thereof

#8226
20050197350
2005-09-08

Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof

#8227
20050196554
2005-09-08

Ink jet recording material

#8228
20050192411
2005-09-01

Triazine compounds, polymers comprising triazine structural units, and method

#8229
20050192314
2005-09-01

Urea derivatives as C-kit modulators

#8230
20050192297
2005-09-01

Quinazolinone compounds with reduced bioaccumulation

#8231
20050192294
2005-09-01

Heteroarylaminopyrazole derivatives useful for the treatment of diabetes

#8232
20050192293
2005-09-01

Amide compounds as ion channel ligands and uses thereof

#8233
20050192291
2005-09-01

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

#8234
20050192287
2005-09-01

Substituted benzazoles and methods of their use as inhibitors of Raf kinase

#8235
20050192286
2005-09-01

Ligands of melanocortin receptors and compositions and methods related thereto

#8236
20050187387
2005-08-25

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

#8237
20050187291
2005-08-25

Aminotetralin-derived urea modulators of vanilloid VR1 receptor

#8238
20050187284
2005-08-25

Integrin receptor inhibitors

#8239
20050187275
2005-08-25

Triazoles as oxytocin antagonists

#8240
20050187264
2005-08-25

Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative

#8241
20050187261
2005-08-25

Hydroxamates as therapeutic agents

#8242
20050187242
2005-08-25

Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

#8243
20050187222
2005-08-25

Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds

#8244
20050187217
2005-08-25

Compositions useful as inhibitors of voltage-gated ion channels

#8245
20050186630
2005-08-25

Extended tethering approach for rapid identification of ligands

#8246
20050186555
2005-08-25

Naphthofluorescein-based metal sensors, and methods of making and using the same

#8247
20050182130
2005-08-18

Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics

#8248
20050182098
2005-08-18

C10 carbamoyloxy substituted taxane compositions

#8249
20050182061
2005-08-18

Phthalimide compounds useful as protein kinase inhibitors

#8250
20050182054
2005-08-18

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

#8251
20050182050
2005-08-18

Therapeutic heterocyclic compounds

#8252
20050182048
2005-08-18

5-substituted-alkylaminopyrazole derivatives as pesticides

#8253
20050182043
2005-08-18

Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them

#8254
20050176964
2005-08-11

Nicotinamide derivatives useful as p38 inhibitors.

#8255
20050176800
2005-08-11

Pyrrolidine derivatives as prostaglandin modulators

#8256
20050176775
2005-08-11

Substituted pyridinones

#8257
20050176771
2005-08-11

2-cyano-4-fluoropyrrolidine derivative or its salt

#8258
20050176763
2005-08-11

3-Thia-4-arylquinolin-2-one potassium channel modulators

#8259
20050176733
2005-08-11

Chk-1 inhibitors

#8260
20050176726
2005-08-11

Vanilloid receptor ligands and their use in treatments

#8261
20050176724
2005-08-11

Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors

#8262
20050176719
2005-08-11

Pyrazinone derivatives

#8263
20050176713
2005-08-11

Amide derivatives as glycogen synthase kinase 3-β inhibitors

#8264
20050176712
2005-08-11

Integrin expression inhibitor

#8265
20050176701
2005-08-11

Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same

#8266
20050171354
2005-08-04

Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists

#8267
20050171196
2005-08-04

2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same

#8268
20050171175
2005-08-04

Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

#8269
20050171172
2005-08-04

Amide derivatives as PDGFR modulators

#8270
20050171171
2005-08-04

Amide derivatives as FLT-3 modulators

#8271
20050171164
2005-08-04

5-substituted-alkylaminopyrazole derivatives as pesticides

#8272
20050171156
2005-08-04

Prodrugs of potassium channel inhibitors

#8273
20050171153
2005-08-04

Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases

#8274
20050171148
2005-08-04

Aryl and heteroaryl compounds, compositions, and methods of use

#8275
20050171146
2005-08-04

Non-peptidic BRS-3 agonists

#8276
20050171132
2005-08-04

Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists

#8277
20050171131
2005-08-04

Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists

#8278
20050171098
2005-08-04

MCH antagonists and their use in the treatment of obesity

#8279
20050165074
2005-07-28

Amide derivatives as C-KIT modulators

#8280
20050165050
2005-07-28

Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors

#8281
20050165049
2005-07-28

Vanilloid receptor ligands and their use in treatments

#8282
20050165046
2005-07-28

Vanilloid receptor ligands and their use in treatments

#8283
20050165036
2005-07-28

Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists

#8284
20050165031
2005-07-28

Urea derivatives as ABL modulators

#8285
20050165028
2005-07-28

Vanilloid receptor ligands and their use in treatments

#8286
20050165024
2005-07-28

Isoxazolyl urea derivatives as kinase modulators

#8287
20050165021
2005-07-28

Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade

#8288
20050165018
2005-07-28

Retinoic acid mimetic anilides

#8289
20050165007
2005-07-28

Benzimidazoles and analogs thereof as antivirals

#8290
20050165003
2005-07-28

N-substituted benzene sulfonamides

#8291
20050159473
2005-07-21

3-substituted oxindole β3 agonists

#8292
20050159467
2005-07-21

5-Aryltetrazole compounds and uses thereof

#8293
20050159463
2005-07-21

Indole derivatives

#8294
20050159437
2005-07-21

Pharmaceutical agents

#8295
20050159418
2005-07-21

5-Aryltetrazoles compounds and compositions thereof

#8296
20050159416
2005-07-21

Compounds, compositions and methods

#8297
20050159406
2005-07-21

Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives

#8298
20050158708
2005-07-21

Methods and compositions related to tagging of membrane surface proteins

#8299
20050154039
2005-07-14

5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine

#8300
20050153996
2005-07-14

Compounds that modulate PPAR activity and methods for their preparation

#8301
20050153984
2005-07-14

Vanilloid receptor ligands and their use in treatments

#8302
20050153980
2005-07-14

Substituted indoles

#8303
20050153972
2005-07-14

Triazole compounds

#8304
20050153960
2005-07-14

Substituted arylamine derivatives and methods of use

#8305
20050153957
2005-07-14

β2-adrenoceptor agonists

#8306
20050148777
2005-07-07

Benzopyran compounds useful for treating inflammatory conditions

#8307
20050148650
2005-07-07

Antidepressant

#8308
20050148646
2005-07-07

Dicationic triaryl analogs as anti-protozoan agents

#8309
20050148645
2005-07-07

2-guanidinylimidazolidinedione compounds and methods of making and using thereof

#8310
20050148635
2005-07-07

3-imino-2-indolones for the treatment of depression and/or anxiety

#8311
20050148631
2005-07-07

Amino heterocyclyl inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

#8312
20050148627
2005-07-07

Benzopyran compounds for use in the treatment and prevention of inflammation related conditions

#8313
20050148623
2005-07-07

HIV protease inhibiting compounds

#8314
20050148605
2005-07-07

Amide derivatives as ABL modulators

#8315
20050148588
2005-07-07

LFA-1 antagonist compounds

#8316
20050148586
2005-07-07

Quinoxalinones

#8317
20050148574
2005-07-07

Imidazole compositions useful as inhibitors of protein kinases

#8318
20050148548
2005-07-07

Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

#8319
20050148086
2005-07-07

Fluorescent sensor for phosphate ion and phosphorylated peptide

#8320
20050143447
2005-06-30

C10 heterosubstituted acetate taxane compositions

#8321
20050143446
2005-06-30

Taxanes having a C7 heterosubstituted acetate substituent

#8322
20050143436
2005-06-30

Inhibitors of interleukin-1beta converting enzyme

#8323
20050143426
2005-06-30

Calcium receptor modulating agents

#8324
20050143422
2005-06-30

Biaryl sulfonamides and methods for using same

#8325
20050143387
2005-06-30

4-aminopyrimidines and their use for the antimicrobial treatment of surfaces

#8326
20050143373
2005-06-30

Benzodioxole derivatives

#8327
20050142614
2005-06-30

Methods for ligand discovery

#8328
20050142542
2005-06-30

Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix

#8329
20050137395
2005-06-23

Quinoline derivatives

#8330
20050137243
2005-06-23

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

#8331
20050137234
2005-06-23

Histone deacetylase inhibitors

#8332
20050137228
2005-06-23

Benzyl sulfonamide derivatives

#8333
20050137213
2005-06-23

4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof

#8334
20050137212
2005-06-23

hPPARs activators

#8335
20050137210
2005-06-23

Substituted n-aryl amidines as selective D dopamine receptor antagonists for the treatment of obesity and CNS disorders

#8336
20050137200
2005-06-23

Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use

#8337
20050137196
2005-06-23

Medical devices employing triazine compounds and compositions thereof

#8338
20050137193
2005-06-23

Aryl sulfonamides

#8339
20050137190
2005-06-23

Compositions useful as inhibitors of voltage-gated sodium channels

#8340
20050137187
2005-06-23

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

#8341
20050135737
2005-06-23

Optical interleaver

#8342
20050131032
2005-06-16

(Oxime)carbamoyl fatty acid amide hydrolase inhibitors

#8343
20050131022
2005-06-16

c-fms kinase inhibitors

#8344
20050131018
2005-06-16

Acetylene derivatives as inhibitors of histone deacetylase

#8345
20050131014
2005-06-16

Quinolines and pharmaceutical compositions thereof

#8346
20050130989
2005-06-16

N-arylheteroaromatic products compositions containing them and use thereof

#8347
20050130959
2005-06-16

Inhibitors of cathepsin S

#8348
20050130244
2005-06-16

Assay for entactogens

#8349
20050130243
2005-06-16

Assay for entactogens

#8350
20050130225
2005-06-16

Ecstasy haptens and immunogens

#8351
20050124682
2005-06-09

Substituted cyclic compounds

#8352
20050124675
2005-06-09

Indole compounds

#8353
20050124672
2005-06-09

N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation

#8354
20050124671
2005-06-09

Benzylcycloalkyl amines as modulators of chemokine receptor activity

#8355
20050124664
2005-06-09

Urea thiadiazole inhibitors of plasminogen activator inhibior-1

#8356
20050124654
2005-06-09

Compounds and methods of use

#8357
20050124641
2005-06-09

Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors

#8358
20050124640
2005-06-09

Pyrimidine derivatives useful as inhibitors of PKC-theta

#8359
20050124638
2005-06-09

Benzimidazoles and analogs thereof as antivirals

#8360
20050124625
2005-06-09

Piperazine derivatives and their use as modulators of nuclear hormone receptor function

#8361
20050124619
2005-06-09

Medical devices employing triazine compounds and compositions thereof

#8362
20050124614
2005-06-09

3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis

#8363
20050124607
2005-06-09

5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists

#8364
20050124577
2005-06-09

8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient

#8365
20050119484
2005-06-02

Mitotic kinesin inhibitors

#8366
20050119273
2005-06-02

Small molecule toll-like receptor (TLR) antagonists

#8367
20050119255
2005-06-02

Phenylpyrimidine amines as ige inhibitors

#8368
20050119225
2005-06-02

Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs

#8369
20050113566
2005-05-26

Inhibitors of C-FMS kinase

#8370
20050113440
2005-05-26

Compounds that modulate PPAR activity and methods for their preparation

#8371
20050113414
2005-05-26

Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases

#8372
20050113398
2005-05-26

2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

#8373
20050113390
2005-05-26

Sodium channel blockers

#8374
20050113389
2005-05-26

Sodium channel blockers

#8375
20050113388
2005-05-26

Sodium channel blockers

#8376
20050113358
2005-05-26

Quinoline inhibitors of cGMP phosphodiesterase

#8377
20050113344
2005-05-26

Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases

#8378
20050113341
2005-05-26

Medical devices employing triazine compounds and compositions thereof

#8379
20050107457
2005-05-19

Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith

#8380
20050107427
2005-05-19

Benzyl urea and thiourea derivatives

#8381
20050107395
2005-05-19

Pyridinyl-methyl-ethyl cyclohexanecarboxamides as serotonergic agents

#8382
20050107388
2005-05-19

Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain

#8383
20050107370
2005-05-19

Pyrrole derivatives as antimycobacterial compounds

#8384
20050101781
2005-05-12

Eponemycin and epoxomicin analogs and uses thereof

#8385
20050101779
2005-05-12

Phenylalanine derivatives

#8386
20050101644
2005-05-12

Benzylether amine compounds useful as CCR-5 antagonists

#8387
20050101641
2005-05-12

Aromatic sulfone hydroxamic acids and their use as protease inhibitors

#8388
20050101630
2005-05-12

4-Substituted quinolines as antitumor agents

#8389
20050101590
2005-05-12

Antipruritics

#8390
20050101540
2005-05-12

STAT modulators

#8391
20050100978
2005-05-12

Fluorescent probes for use in protein kinase inhibitor binding assay

#8392
20050096378
2005-05-05

Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives

#8393
20050096375
2005-05-05

Bicyclic [3.1.0] derivatives as glycine transporter inhibitors

#8394
20050096358
2005-05-05

Substituted biaryl amides as C5A receptor modulators

#8395
20050096329
2005-05-05

3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants

#8396
20050096325
2005-05-05

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

#8397
20050096312
2005-05-05

Therapeutic quinolone compounds with 5-ht-antagonistic properties

#8398
20050090669
2005-04-28

Aminoalcohol derivatives as beta-3 adrenergic receptor agonists

#8399
20050090546
2005-04-28

Aspartic protease inhibitors

#8400
20050090505
2005-04-28

Methods of reducing risk of infection from pathogens